(APRIL 6, 2021) David Rettew, M.D., associate professor of psychiatry and pediatrics, discusses parenting and the strategies shared in his book on "Parenting Made Complicated: What Science Really Knows About the Greatest Debates of Early Childhood" in a Yahoo!Life article, titled "Want to Be a Better Parent? Consider Temperament."

A new study in the Journal of the National Cancer Institute authored by Brian Sprague, Ph.D., and colleagues provides an analysis of mammography screening rates during the first five months of the global COVID-19 pandemic. Results show a strong rebound in breast cancer screening rates, but also uncover a cumulative deficit, as well as disparities by race, that researchers say require additional attention to understand and address.

On April 1st, the White House Office of National Drug Control Policy (ONDCP) announced the Biden-Harris Administration’s drug policy priorities (PDF) for year one. Priority one is an expansion of access to evidence-based treatment, which includes identifying and addressing “policy barriers related to contingency management interventions (motivational incentives) for stimulant use disorder” as well as exploring “reimbursement for motivational incentives and digital treatment for addiction, especially stimulant use disorder.”

Sarah Nowak, Ph.D., and David Seward, M.D., Ph.D., were invested as the inaugural holders of a Huber Early Career Green and Gold Professorship of Pathology and Laboratory Medicine during a virtual ceremony March 30. UVM Professor of Pathology and Laboratory Medicine Emerita Sally Huber, Ph.D., established two separate Green and Gold professorships, one in honor of each of her parents, that will provide crucial funding to promising assistant professors who are likely to develop into successful, independent basic scientists or physician-scientists.